How Do Biopharma Professionals Prefer to Job Hunt?  | View as HTML Post Jobs Search Resumes Email Preferences
BioSpaceLike Us on FacebookFollow us on TwitterLinkedInRSSSubscribe

Maximize your exposure through sponsoring a job seeker email sent to over 360,000 job seekers. Buy one sponsorship and receive one FREE – a savings of $2,995! Offer valid through February 18th by mentioning the promo code: FreeJobSeekerEmailAd. Contact your rep today!

Your Career

How Do Biopharma Professionals Prefer to Job Hunt?

To say the biopharma industry has had a few tough years would be an understatement. With big pharma layoffs rampant and outsourcing becoming more prominent, biopharmaceutical workers have feared for their jobs. Read More.

Your Career

Top 5 Toughest Conversations for HR

Kids have it easy. If something doesn't look right, smell right or seem right, kids don't hesitate to state the obvious. They don't worry about hurting someone's feelings. They just say it. I'll never forget the time I was playing with my six-month-old daughter when a boy asked me when my other baby was going to be born. Read More.

With our niche audience of biotechnology and pharmaceutical professionals, BioSpace is the ideal place to find candidates for your hard to fill positions. If your job posting needs an extra boost, feature it on the homepage and in a daily newsletter for an entire week as a Top Job!

For more information about this productand other recruitment and advertising solutions, contact Biospace at (888) BIOSPACE or today!
Biogen Idec, Inc. (Massachusetts) (BIIB) to Buy Elan Corporation PLC (ELN)'s Tysabri Rights for $3.25 Billion
Elan Corporation, plc (ELN) today announced that it has agreed to restructure the Tysabri® collaboration with Biogen Idec. Under the terms of the agreement, Elan will move from the current 50:50 business collaboration to an upfront payment of $3.25 billion and a double digit tiered royalty structure for the complete asset. Learn More »
Where, Oh Where, Has All the Pharma Talent Gone?
File this under 'sad irony.' Now that the pharmaceutical industry has tossed thousands of people overboard during the last decade – an estimated 150,000 or so just since 2009 – a slight majority of drugmakers complain that it has become increasingly difficult to find the right talent and most worry they will not have access to the people they need to hire, according to a report from PricewaterhouseCoopers. Learn More »
The Medicines Company (MDCO) Buys Cholesterol Drug Rights From Alnylam Pharmaceuticals (ALNY) for Up to $205 Million
The Medicines Company (MDCO) and Alnylam Pharmaceuticals, Inc. (ALNY), a leading RNAi therapeutics company, announced today that they have formed an exclusive global alliance for the development and commercialization of Alnylam's ALN-PCS RNAi therapeutic program for the treatment of hypercholesterolemia. Learn More »

Post Your:   News   |   Jobs   |   Company Profile   |   Event   |   Advertising/Sponsorship

This email was sent by Please distribute this e-cast freely. Subscribe to our newsletter. To unsubscribe or update your email preferences, click here. This request may take up to 10 business days to take effect. is an onTargetjobs, Inc. company and respects your time and privacy. is not responsible for offers, products, services, or other information expressed or made available by third parties and provided by any off-site Internet page referenced through this email's hypertext. While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. To guarantee receipt of emails, add to your address book.

Contact the News Team Email:; Toll Free: (877) 277-7585; 6465 S. Greenwood Plaza Blvd., Ste. 400, Centennial, CO 80111
Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu

© 2012 onTargetjobs, Inc. All rights reserved. is a registered trademark of onTargetjobs, Inc. All other trademarks and registered trademarks are the property of their respective owners.